el-Houseini ME - Search Results

1

Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects.

Afifi AM, El-Husseiny AM, Tabashy RH, Khalil MA, El-Houseini ME. Afifi AM, et al. Among authors: el houseini me. Asian Pac J Cancer Prev. 2019 Oct 1;20(10):3007-3013. doi: 10.31557/APJCP.2019.20.10.3007. Asian Pac J Cancer Prev. 2019. PMID: 31653148 Free PMC article.

2

Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study.

El-Houseini ME, Ismail A, Abdelaal AA, El-Habashy AH, Abdallah ZF, Mohamed MZ, El-Hadidi M, Cho WCS, Ahmed H, Al-Shafie TA. El-Houseini ME, et al. Biochemistry (Mosc). 2019 Aug;84(8):941-953. doi: 10.1134/S0006297919080108. Biochemistry (Mosc). 2019. PMID: 31522676

3

A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: a pilot study.

Hatab HM, Abdel Hamid FF, Soliman AF, Al-Shafie TA, Ismail YM, El-Houseini ME. Hatab HM, et al. Among authors: el houseini me. J Gastrointest Oncol. 2019 Aug;10(4):766-776. doi: 10.21037/jgo.2019.03.07. J Gastrointest Oncol. 2019. PMID: 31392057 Free PMC article.

4

A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine.

Abdellateif MS, Shaarawy SM, Kandeel EZ, El-Habashy AH, Salem ML, El-Houseini ME. Abdellateif MS, et al. Among authors: el houseini me. Oncol Lett. 2018 Jul;16(1):529-535. doi: 10.3892/ol.2018.8631. Epub 2018 May 4. Oncol Lett. 2018. PMID: 29928442 Free PMC article.

5

Cancer cell death induced by nanomagnetolectin.

AlSadek DMM, Badr HA, Al-Shafie TA, El-Bahr SM, El-Houseini ME, Djansugurova LB, Li CZ, Ahmed H. AlSadek DMM, et al. Among authors: el houseini me. Eur J Cell Biol. 2017 Sep;96(6):600-611. doi: 10.1016/j.ejcb.2017.04.005. Epub 2017 May 10. Eur J Cell Biol. 2017. PMID: 28521959 Free PMC article.

6

Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis.

El-Houseini ME, El-Agoza IA, Sakr MM, El-Malky GM. El-Houseini ME, et al. Exp Ther Med. 2017 Jan;13(1):29-36. doi: 10.3892/etm.2016.3952. Epub 2016 Dec 2. Exp Ther Med. 2017. PMID: 28123463 Free PMC article.

7

Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Badr HA, AlSadek DM, El-Houseini ME, Saeui CT, Mathew MP, Yarema KJ, Ahmed H. Badr HA, et al. Among authors: el houseini me. Biomaterials. 2017 Feb;116:158-173. doi: 10.1016/j.biomaterials.2016.11.044. Epub 2016 Nov 25. Biomaterials. 2017. PMID: 27926828 Free PMC article. Review.

8

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma.

Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA. Gabeen AA, et al. Among authors: el houseini me. J Hepatocell Carcinoma. 2014 Jun 9;1:55-63. doi: 10.2147/JHC.S56012. eCollection 2014. J Hepatocell Carcinoma. 2014. PMID: 27508176 Free PMC article.

9

Potential role of curcumin and taurine combination therapy on human myeloid leukemic cells propagated in vitro.

El-Houseini ME, Refaei MO, Amin AI, Abol-Ftouh MA. El-Houseini ME, et al. Leuk Lymphoma. 2013 Oct;54(10):2281-7. doi: 10.3109/10428194.2013.776167. Epub 2013 Apr 11. Leuk Lymphoma. 2013. PMID: 23418874

10

Serological biomarkers of hepatocellular carcinoma in Egyptian patients.

El-Tayeh SF, Hussein TD, El-Houseini ME, Amer MA, El-Sherbini M, Elshemey WM. El-Tayeh SF, et al. Among authors: el houseini me. Dis Markers. 2012;32(4):255-63. doi: 10.3233/DMA-2011-0883. Dis Markers. 2012. PMID: 22430192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results